Display options
Share it on

Daru. 2014 Jan 08;22(1):16. doi: 10.1186/2008-2231-22-16.

Antidepressant effects of crocin and its effects on transcript and protein levels of CREB, BDNF, and VGF in rat hippocampus.

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences

Faezeh Vahdati Hassani, Vahideh Naseri, Bibi Marjan Razavi, Soghra Mehri, Khalil Abnous, Hossein Hosseinzadeh

Affiliations

  1. Pharmaceutical Research Center, Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. [email protected].

PMID: 24401376 PMCID: PMC3927874 DOI: 10.1186/2008-2231-22-16

Abstract

BACKGROUND: Antidepressants have been shown to affect levels of brain-derived neurotrophic factor (BDNF) and VGF (non-acronymic) whose transcriptions are dependent on cAMP response element binding protein (CREB) in long term treatment. The aim of this study was to verify the subacute antidepressant effects of crocin, an active constituent of saffron (Crocus sativus L.), and its effects on CREB, BDNF, and VGF proteins, transcript levels and amount of active, phosphorylated CREB (P-CREB) protein in rat hippocampus.

METHODS: Crocin (12.5, 25, and 50 mg/kg), imipramine (10 mg/kg; positive control) and saline (1 mL/kg; neutral control) were administered intraperitoneally (IP) to male Wistar rats for 21 days. The antidepressant effects were studied using the forced swimming test (FST) on day 21 after injection. Protein expression and transcript levels of genes in the rat hippocampus were evaluated using western blot and quantitative reverse transcription-polymerase chain reaction (qRT-PCR), respectively.

RESULTS: Crocin significantly reduced the immobility time in the FST. Western blot analysis showed that 25 and 50 mg/kg of crocin increased the levels of CREB and BDNF significantly and dose dependently. All doses of crocin increased the VGF levels in a dose-dependent manner. Levels of p-CREB increased significantly by 50 mg/kg dose of crocin. Only 12.5 mg/kg crocin could significantly increase the transcript levels of BDNF. No changes in CREB and VGF transcript levels were observed in all groups.

CONCLUSIONS: These results suggest that crocin has antidepressant-like action by increasing CREB, BDNF and VGF levels in hippocampus.

References

  1. Prog Neuropsychopharmacol Biol Psychiatry. 2005 Feb;29(2):261-5 - PubMed
  2. Psychopharmacology (Berl). 2011 Jul;216(1):75-84 - PubMed
  3. Acta Pharmacol Sin. 2011 Jan;32(1):3-11 - PubMed
  4. Nat Med. 2007 Dec;13(12):1476-82 - PubMed
  5. Phytomedicine. 2008 Jun;15(6-7):491-5 - PubMed
  6. J Nat Med. 2010 Jan;64(1):24-30 - PubMed
  7. Psychopharmacology (Berl). 2001 Nov;158(2):205-12 - PubMed
  8. Fitoterapia. 2006 Sep;77(6):446-8 - PubMed
  9. Fitoterapia. 2005 Dec;76(7-8):722-4 - PubMed
  10. Am J Psychiatry. 2004 Nov;161(11):1957-66 - PubMed
  11. Lancet. 1997 May 24;349(9064):1498-504 - PubMed
  12. Phytother Res. 2009 Jun;23(6):768-74 - PubMed
  13. J Neural Transm (Vienna). 2010 Oct;117(10):1131-7 - PubMed
  14. Pak J Biol Sci. 2010 Jul 15;13(14):691-8 - PubMed
  15. Behav Brain Res. 2009 Feb 11;197(2):262-78 - PubMed
  16. Biol Psychiatry. 2006 Jun 15;59(12):1136-43 - PubMed
  17. Am J Psychiatry. 2000 Jan;157(1):115-8 - PubMed
  18. J Clin Psychiatry. 1982 Nov;43(11 Pt 2):14-21 - PubMed
  19. Biol Psychiatry. 2006 Jun 15;59(12):1144-50 - PubMed
  20. Phytomedicine. 2008 Dec;15(12):1032-7 - PubMed
  21. Behav Brain Res. 2011 Aug 1;221(1):166-71 - PubMed
  22. Neuropsychopharmacology. 2004 Oct;29(10):1831-40 - PubMed
  23. Phytother Res. 2010 May;24(5):726-30 - PubMed
  24. BMC Pharmacol. 2002 Mar 15;2:7 - PubMed
  25. Nat Rev Neurosci. 2005 Mar;6(3):241-6 - PubMed
  26. Neuropsychobiology. 2005;51(4):234-8 - PubMed
  27. J Affect Disord. 1997 Mar;43(1):27-39 - PubMed
  28. Fitoterapia. 2012 Jul;83(5):888-95 - PubMed
  29. J Neurosci. 1995 Mar;15(3 Pt 1):1768-77 - PubMed
  30. Nutr Cancer. 1991;16(1):67-72 - PubMed
  31. Drug Discov Today. 2005 Apr 15;10(8):578-85 - PubMed
  32. Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):3908-13 - PubMed
  33. J Neurobiol. 1994 Nov;25(11):1334-48 - PubMed
  34. NeuroRx. 2005 Oct;2(4):590-611 - PubMed
  35. Phytother Res. 2010 Jul;24(7):990-4 - PubMed
  36. Phytomedicine. 2006 Feb;13(3):199-204 - PubMed
  37. Phytother Res. 2012 Mar;26(3):381-6 - PubMed
  38. Planta Med. 2013 Apr;79(6):447-51 - PubMed
  39. Phytother Res. 2013 Apr;27(4):475-83 - PubMed
  40. Iran J Basic Med Sci. 2013 Jan;16(1):56-63 - PubMed
  41. Psychopharmacology (Berl). 1995 Sep;121(1):66-72 - PubMed
  42. Nature. 1977 Apr 21;266(5604):730-2 - PubMed
  43. Nutr Cancer. 1999;35(2):120-6 - PubMed
  44. J Neurosci. 1996 Apr 1;16(7):2365-72 - PubMed
  45. Sci Signal. 2008 May 06;1(18):pe19 - PubMed
  46. Neuropharmacology. 2003 Jun;44(7):903-10 - PubMed
  47. Iran J Basic Med Sci. 2013 Jan;16(1):12-26 - PubMed
  48. J Neural Transm (Vienna). 2007;114(4):431-44 - PubMed
  49. Iran J Basic Med Sci. 2013 Jan;16(1):64-72 - PubMed
  50. Neuropsychopharmacology. 2002 May;26(5):605-14 - PubMed
  51. Methods. 2001 Dec;25(4):402-8 - PubMed
  52. Behav Brain Res. 2006 Oct 2;173(1):112-5 - PubMed
  53. Neuropsychopharmacology. 2004 Dec;29(12):2189-99 - PubMed

Publication Types